Georg N.
- Country
- Germany
- Department
- Medizinische Klinik II
Research Overview
- A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis [Lp(a)FRONTIERS CAVS]
- Efficacy and Safety Evaluation of Subcutaneous Selatogrel in Preventing Recurrent Acute Myocardial Infarction in Post-AMI Patients
- Evaluation of the Efficacy and Safety of BI 690517 and Empagliflozin in Patients with Symptomatic Heart Failure and LVEF ≥40%: A Phase III Randomized Controlled Trial
Data & Insights
Has run more than one trial at 598 of 1172 partner sites.
Specializations
Cardiovascular Disease Management
This investigator specializes in treating complex heart failure conditions, with particular emphasis on developing innovative therapeutic approaches for patients with reduced left ventricular ejection fraction.
- Heart Failure Treatment Optimization
- Cardiovascular Mortality Prevention
- Combined Therapy Approaches
Cardiac Emergency Care
The investigator focuses on advanced treatments for Takotsubo syndrome and investigates novel therapeutic applications of established medications for acute cardiac conditions.
- Takotsubo Syndrome Management
- Myocardial Damage Assessment
- Innovative Treatment Protocols
Complex Cardiac Interventions
Expertise in managing patients with concurrent atrial fibrillation and acute coronary syndromes, particularly focusing on interventional procedures and antiplatelet therapy optimization.
- Coronary Intervention Strategies
- Antithrombotic Management
- Post-Myocardial Infarction Care
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.